期刊文献+

聚维酮碘膜剂的制备及质量控制 被引量:8

Preparation and Quality Control of PVP-I Film
下载PDF
导出
摘要 目的:研制高水溶性聚维酮碘膜剂,并建立其质量控制方法。方法:用聚维酮碘、甘油、蒸馏水和水溶性成膜材料聚乙稀醇05-88制备膜剂;以电位滴定法测定聚维酮碘含量,并分别考察成品在棕色和无色玻璃瓶中的稳定性。结果:制备的膜剂完整光洁、色泽均匀、厚度一致;平均加样回收率为99.03%(RSD=0.75%);膜剂在棕色玻璃瓶中60d内外观和含量均无明显变化,而在无色玻璃瓶中含量明显降低,外观也变为淡黄色。结论:本制剂的制备工艺简便,质量控制方法准确可靠。 OBJECTIVE: To prepare PVP -Ⅰ film agent of high water solubility and to establish a method for its quality control. METHODS: The film was prepared by mixing PVP -Ⅰ, glycerol, distilled water and PVA05- 88. The content of povidone iodine was determined with electric titration. The stability of the preparation stored in brown glass and colorless glass was investigated.RESULTS: The prepared film was integrated, clear and even in color and size. The average recovery was 99.03% (RSD=0.75% ) . The film stored in brown glass showed no evident changes in appearance and content within 60d, while that in colorless glass was found to have a decrease in content and yellowish appearance. CONCLUSION: The preparation technology is simple and method of quality control is accurate and reliable.
出处 《中国药房》 CAS CSCD 北大核心 2006年第6期430-431,共2页 China Pharmacy
关键词 聚维酮碘膜剂 制备 质量控制 稳定性 PVP -Ⅰ film Preparation Quality control Stability
  • 相关文献

参考文献8

  • 1Leven H,LeVeen RF,LeVeen EG,The mythology of povidone-iodine and the development of self-sterilizing plastics[J].Surg Gynecol Obstet,1993,176(2):183.
  • 2Philips RH,Czaplicka E,Gracz H.Betadine for antiseptics of the Conjunctival Sac[J].Klin Oczna,1997(7):255.
  • 3李勤耕.聚维酮碘膜剂.中国发明专利[P].ZL98111921.
  • 4Kawana R,Kitamura T,Nakagomi O,et al.Inactivation of human viruses by povidone-iodine in comparison with other antiseptics[J].Dermatology,1997,195(Suppl 2):29.
  • 5Sokal DC,Hermonat PL.Inactivation of Papillomavirus by low concentrations of povidone-iodine[J].Sex Transm Dis,1995,22(1):22.
  • 6Rikimard T,Kondo M,Kondo S,et al.Bactericidal activities of povidone-iodine against Mycobacterium[J].Dermatology,1997,195(Suppl):104.
  • 7王俏,张望刚,陈国神.口腔溃疡膜的研制[J].中国医院药学杂志,2004,24(6):346-347. 被引量:11
  • 8王俏,陈国神.阴道给药制剂的研究进展[J].中国现代应用药学,2005,22(1):34-37. 被引量:15

二级参考文献31

  • 1金毓翠 王迪钧 曹霖 等.治疗妇科疾病用局部给药缓释装置[P].中国专利CN2416900Y.2001-1-31.
  • 2Woolfson AD, Elliott GRE, Gilligan CA, et al. Design of an intravaginal ring for the controlled delivery of 17β-estrediol as its 3-acetate ester [J]. J Controlled Release, 1999,61:319.
  • 3Chang JY, Oh YK, Choi HG, et al . Rheologlcal evaluation of thevrnosensifive and mucoadhesive vaginal gels in physiological conditions [J]. Int J Pharm, 2002, 241(1): 155.
  • 4Gagne N, Cormier H, Omar RF, et al. Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9 [ J ]. Sex Transm Dis, 1999,26:177.
  • 5Livengood CH, Seper DE, Sheeham KL, et al. Comparison of once -daily and twice-daily dosing of 0.75% metrinidasole gel in the treatment of bacterial vaginosis [J]. Sex Transm Dis, 1999,26:137.
  • 6Valenta C, Marschutz M, Egyed C,et al. Evaluation of the inhibition effect of thiolated poly ( acrylates ) on vaginal membrane and release of the model drug LH-RH[J]. J Pharm Pharmacol,2002,54(5) : 603.
  • 7Chanrachakul B, Herabutya Y, Punyavachira P. Randimized comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term [J]. Obstet Gynecol, 2000,9(4) :549.
  • 8Digenis GA, Nosek MF, Darwazeh NB, et al. Novel vaginal controlled-delivery systems incorporating coprecipotates of nonoxynol-9 [J]. Pharm Dev Technol, 1999,4:421.
  • 9Manonai J, Theppisai U, Chittaeharoen A. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms [J]. J Med Assoc Thai, 2001,84(7) :1015.
  • 10Manonai J, Theppisni U, Suthutvoravut S, et al. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study [ J]. J Obstet Gynaecol Res, 2001,27(5) :255.

共引文献24

同被引文献50

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部